Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 12, 2016 9:46 PM ET

Healthcare Equipment and Supplies

Company Overview of Sensus Healthcare, Inc.

Company Overview

Sensus Healthcare, Inc., a medical device company, manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. Superficial radiation therapy is based on a technology with clinical use treating various benign and malignant skin conditions. It offers SRT-100, a mobile superficial radiation therapy system primarily for the non-invasive treatment of non-melanoma skin cancer; SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and comprehensive dosimetry parameter; SRT-100 Lyn...

851 Broken Sound Parkway NW

Suite 215

Boca Raton, FL 33487

United States

Founded in 2010

Phone:

561-922-5808

Fax:

561-948-2071

Key Executives for Sensus Healthcare, Inc.

Chairman, Chief Executive Officer and President
Age: 62
Chief Financial Officer
Age: 57
Chief Operating Officer and Chief Technology Officer
Executive Vice President of Oncology and International Sales
Senior Vice President of Strategic Initiatives and Dermatology
Compensation as of Fiscal Year 2015.

Sensus Healthcare, Inc. Key Developments

Sensus Healthcare Receives FDA 510k Clearance for Next Generation Image Guided Superficial Radiotherapy SRT-100 Vision

Sensus Healthcare announced FDA clearance for the next generation SRT-100 Vision system at the American Society for Radiation Oncology (ASTRO) 2015 exhibition in San Antonio, TX. The next generation SRT-100 Vision features integration of multi-modal therapy and image-guidance technologies with software integration to provide enhanced precision, safety, and quality in delivering superficial radiotherapy (SRT), electronic brachytherapy (eBx), and Grenz Ray therapy (GRT) in a seamlessly integrated and scalable platform. The SRT-100 Vision is also FDA-cleared for the treatment of keloids following surgical removal, allowing prophylactic treatment for this chronic condition to general surgery patients who are predisposed to their development.

Similar Private Companies By Industry

Company Name Region
TheraTogs, Inc. United States
PhiloMetron Inc. United States
Carmell Therapeutics Corporation United States
M-Pact Worldwide, LLC United States
Adroit Medical Systems, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 28, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sensus Healthcare, Inc., please visit www.sensushealthcare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.